Trial Profile
A prospective, multicenter, open-label, randomized, comparative study to evaluate the efficacy, safety, and tolerability of ertapenem versus ceftriaxone/metronidazole in the treatment of intra-abdominal infections in adults
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary) ; Ceftriaxone; Metronidazole
- Indications Bacterial infections; Intra-abdominal infections
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 26 Jul 2007 New trial record.